Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Building a hypophosphatasia care team starts with an endocrinologist or metabolic bone specialist to direct treatment and a geneticist to confirm the ALPL diagnosis, because HPP is a rare inherited disorder affecting mineralization throughout the body. These two specialists anchor care, then coordinate referrals to dentists, orthopedists, rheumatologists, physical therapists, nephrologists, and pain specialists as symptoms emerge. Adults often reach diagnosis after years of unexplained fractures, dental loss, or muscle pain, so the right lead clinician can dramatically shorten that path. Because HPP presents differently at every age and severity level, team composition varies widely from person to person. There are several important factors to consider when assembling and coordinating your care, including who orders enzyme replacement therapy and how specialists communicate; see below to understand more.
If you are experiencing unexplained fractures, early tooth loss, chronic bone pain, or persistent fatigue, a free, instant, online symptom check can help you organize your symptoms into clear patterns before your next appointment, which matters because rare conditions like HPP are often missed when concerns are raised one at a time across different providers.
Last reviewed for medical accuracy: 08/18/2026
Hypophosphatasia (HPP) is a rare inherited disorder characterized by defective bone mineralization and low activity of the enzyme tissue-nonspecific alkaline phosphatase (TNSALP). Because HPP affects multiple organ systems—bones, teeth, kidneys and sometimes the nervous system—managing it well means assembling a team of specialists who understand its complexity. At the heart of that team are endocrinologists and geneticists, who guide diagnosis, tailor treatment plans and coordinate care.
• Endocrinologists
• Geneticists
Together, these specialists review clinical findings, imaging studies and genetic tests. They develop personalized care pathways that address both immediate needs (bone pain, fractures, respiratory compromise) and long-term outcomes (growth, dental health, mobility).
When asking “What specialist treats Hypophosphatasia?”, the answer is a multidisciplinary one, but the lead physicians are:
These experts frequently collaborate with other professionals to ensure comprehensive management.
Beyond endocrinologists and geneticists, the following specialists play key roles. Each member addresses specific aspects of HPP, ensuring coordinated care:
• Centralized Case Management
• Regular Multidisciplinary Meetings
• Patient and Family Education
• Transition Planning
• Track Symptoms and Medications
• Use a Symptom Checker
• Bring Questions and Goals
• Invite a Care Partner
Although HPP is usually a chronic condition, certain signs require prompt evaluation:
If you experience any of these, seek emergency care and speak to a doctor immediately.
Building an effective HPP care team hinges on specialists who truly understand rare bone diseases. Endocrinologists and geneticists should lead the effort, supported by orthopedic surgeons, dentists, therapists, nutritionists and others. With clear communication, coordinated planning and patient engagement, you can optimize health outcomes and quality of life.
Remember: this information is a guide, not a substitute for professional medical advice. Speak to a doctor about anything that could be life threatening or serious.
(References)
* Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Dahir KM, Nunes ME. Hypophosphatasia. 1993. PMID: 20301329.
* Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Marini JC, Dang Do AN. Osteogenesis Imperfecta. 2000. PMID: 25905334.
* Linglart A, Biosse-Duplan M. Hypophosphatasia. Curr Osteoporos Rep. 2016 Jun;14(3):95-105. doi: 10.1007/s11914-016-0309-0. PMID: 27084188.
* Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017 Sep;122(1-2):4-17. doi: 10.1016/j.ymgme.2017.07.010. Epub 2017 Jul 25. PMID: 28888853.
* Fenn JS, Lorde N, Ward JM, Borovickova I. Hypophosphatasia. J Clin Pathol. 2021 Oct;74(10):635-640. doi: 10.1136/jclinpath-2021-207426. Epub 2021 Apr 30. PMID: 33931563.
* Tournis S, Yavropoulou MP, Polyzos SA, Doulgeraki A. Hypophosphatasia. J Clin Med. 2021 Dec 1;10(23). doi: 10.3390/jcm10235676. Epub 2021 Dec 1. PMID: 34884378; PMCID: PMC8658462.
* Farman MR, Rehder C, Malli T, Rockman-Greenberg C, Dahir K, Martos-Moreno GÁ, Linglart A, Ozono K, Seefried L, Del Angel G, Webersinke G, Barbazza F, John LK, Delana Mudiyanselage SMA, Högler F, Nading EB, Huggins E, Rush ET, El-Gazzar A, Kishnani PS, Högler W. The Global ALPL gene variant classification project: Dedicated to deciphering variants. Bone. 2024 Jan;178:116947. doi: 10.1016/j.bone.2023.116947. Epub 2023 Oct 26. PMID: 37898381.
* Rush E, Brandi ML, Khan A, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Lewiecki EM, Linglart A, M'Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Roux C, Seefried L, Starling SR, Ward L, Yao L, Brignardello-Petersen R, Simmons JH. Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group. Osteoporos Int. 2024 Jan;35(1):1-10. doi: 10.1007/s00198-023-06843-2. Epub 2023 Nov 20. PMID: 37982855; PMCID: PMC10786745.
* Khan AA, Brandi ML, Rush ET, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Linglart A, M'Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Roux C, Seefried L, Simmons JH, Starling SR, Ward LM, Yao L, Brignardello-Petersen R, Lewiecki EM. Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults. Osteoporos Int. 2024 Mar;35(3):431-438. doi: 10.1007/s00198-023-06844-1. Epub 2023 Nov 20. PMID: 37982857; PMCID: PMC10866785.
* Seefried L, Genest F, Hofmann C, Brandi ML, Rush E. Diagnosis and Treatment of Hypophosphatasia. Calcif Tissue Int. 2025 Mar 6;116(1):46. doi: 10.1007/s00223-025-01356-y. Epub 2025 Mar 6. PMID: 40047955; PMCID: PMC11885340.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.